Change Healthcare can notify patients whose sensitive health information has been exposed as a result of the massive security breach at the health care payments
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture. Subscribe AnnuallySubscribe Monthly Already
NEW YORK and BERLIN, May 23, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) has emerged victorious in its prolonged legal battle with the company’s former CEO, Dr. Raza Bokhari. Following years
On April 26, 2024, the Federal Trade Commission (FTC) issued a significant final rule amending its Health Breach Notification Rule (HBN Rule). This amendment aims
VANCOUVER, BC, May 31, 2024 /CNW/ – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada-licensed GMP psychedelics pharmaceutical manufacturer specializing in controlled substances such
Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) (“Lobe” or the “Company”), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced
Earlier today, staff from the U.S. health regulatory body expressed concerns regarding the interpretation of data from trials on the psychedelic drug MDMA for treating
What You Should Know: – ShiftMed, the leader in On Demand workforce technology, announces its partnership with Children’s Minnesota, an award-winning healthcare system delivering high
What You Should Know: – Kahuna, the leading skills and competency management software, has entered into a copyright and know-how agreement with Mayo Clinic to